Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maneesh Jain

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Gastroenterology|February 27, 2022
Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal HeterogeneityKoelina Ganguly, Jesse L Cox, Dario Ghersi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2006
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)Subhash C Chauhan, Ajay P Singh, Fernanda Ruiz, et al.
Expert Opinion on Therapeutic Targets|May 3, 2017
MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinomaShailendra K Gautam, Sushil Kumar, Andrew Cannon, et al.
The Lancet. Oncology|November 18, 2008
Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancerAjay P Singh, Shantibhusan Senapati, Moorthy P Ponnusamy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2005
Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49Subhash C Chauhan, Maneesh Jain, Erik D Moore, et al.
Cytokine & Growth Factor Reviews|November 27, 2021
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexiaJawed Akhtar Siddiqui, Ramesh Pothuraju, Parvez Khan, et al.
Expert Opinion on Therapeutic Targets|July 13, 2018
MUC16 as a novel target for cancer therapyAbhijit Aithal, Sanchita Rauth, Prakash Kshirsagar, et al.
Plos One|February 15, 2013
MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cellsPartha Mukhopadhyay, Imayavaramban Lakshmanan, Moorthy P Ponnusamy, et al.
European Journal of Human Genetics : EJHG|November 25, 2005
Optimal genotype determination in highly multiplexed SNP dataMartin Moorhead, Paul Hardenbol, Farooq Siddiqui, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 10, 2014
Nano-immunoassay with improved performance for detection of cancer biomarkersAlexey V Krasnoslobodtsev, María P Torres, Sukhwinder Kaur, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Gastroenterology|February 27, 2022
Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal HeterogeneityKoelina Ganguly, Jesse L Cox, Dario Ghersi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2006
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)Subhash C Chauhan, Ajay P Singh, Fernanda Ruiz, et al.
Expert Opinion on Therapeutic Targets|May 3, 2017
MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinomaShailendra K Gautam, Sushil Kumar, Andrew Cannon, et al.
The Lancet. Oncology|November 18, 2008
Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancerAjay P Singh, Shantibhusan Senapati, Moorthy P Ponnusamy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2005
Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49Subhash C Chauhan, Maneesh Jain, Erik D Moore, et al.
Cytokine & Growth Factor Reviews|November 27, 2021
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexiaJawed Akhtar Siddiqui, Ramesh Pothuraju, Parvez Khan, et al.
Expert Opinion on Therapeutic Targets|July 13, 2018
MUC16 as a novel target for cancer therapyAbhijit Aithal, Sanchita Rauth, Prakash Kshirsagar, et al.
Plos One|February 15, 2013
MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cellsPartha Mukhopadhyay, Imayavaramban Lakshmanan, Moorthy P Ponnusamy, et al.
European Journal of Human Genetics : EJHG|November 25, 2005
Optimal genotype determination in highly multiplexed SNP dataMartin Moorhead, Paul Hardenbol, Farooq Siddiqui, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 10, 2014
Nano-immunoassay with improved performance for detection of cancer biomarkersAlexey V Krasnoslobodtsev, María P Torres, Sukhwinder Kaur, et al.
Pageof 16